Repare Therapeutics Enters Definitive Agreement to Be Acquired by Xeno Therapeutics

Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 20...

November 17, 2025 | Monday | News
Amneal Earns FDA Approval for First Generic Iohexol, Targeting $652M U.S. Market

Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FD...

November 17, 2025 | Monday | News
Angelini Ventures Expands to Asia with Singapore Hub to Power Biotech and Healthtech Innovation

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelin...

November 14, 2025 | Friday | News
Atomic Launches to Bridge the Gap Between Breakthrough MedTech Innovation and Venture-Ready Business

-Atomic launches today as a first-of-its-kind service offering for MedTech startups built to bridge the gap between breakthrough concepts and investor-re...

November 13, 2025 | Thursday | News
Basel, Switzerland Emerges as a Global Haven for Life Sciences Talent

Continued uncertainty in the US has many of the world's top scientists considering the Basel area.  Between the government shutdown, crippling inte...

November 12, 2025 | Wednesday | News
N2OFF Completes Merger with MitoCareX Bio to Expand into Cancer Drug Discovery Targeting Mitochondrial Proteins

N2OFF, Inc. a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the ...

October 31, 2025 | Friday | News
SK pharmteco Invests $6.1 Million to Expand U.S. Peptide Manufacturing Capabilities in California

SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facili...

October 24, 2025 | Friday | News
Elevara Medicines Secures $70M Series A to Advance First-in-Class RA Therapy ELV001

Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed ...

October 23, 2025 | Thursday | News
Sharp Commits $100 Million to Expand Sterile and Packaging Capacity Across U.S. and Europe

    Sterile fill/finish capacity added in Lee, MA, and injectable assembly and packaging capacity added in the Netherlands, Belgium, Allent...

October 23, 2025 | Thursday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News
Adcytherix Raises €105 Million Series A to Advance Next-Generation Antibody–Drug Conjugates with Novel Payloads

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...

October 20, 2025 | Monday | News
Rani Therapeutics Enters $1 Billion Collaboration with Chugai for Oral Biologics Development

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $10...

October 20, 2025 | Monday | News
Qualio Introduces AI-Powered Compliance Intelligence to Redefine Life Sciences Regulatory Management

AI-powered gap analysis, continuous compliance monitoring, real-time visibility, and pre-built life sciences frameworks help organizations reduce audit p...

October 15, 2025 | Wednesday | News
Excellergy Launches with $70M Series A to Redefine Allergy Treatment with First-in-Class Trifunctional ECRIs

-Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of alle...

October 14, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close